Highlights

ISO accreditation

We’re currently working towards International Organization for Standardization (ISO) accreditation for the EQA programs that EuroFlow, EuroMRD, and EuroClonality offer.

ESLHO Symposium

The 13th ESLHO Symposium ‘Multi-omics approaches for diagnosis and monitoring of hematological malignancies’ was held on November 7, 2024, in Lisbon, Portugal.

At this meeting, which was attended by more than 250 participants, the audience was treated to many interesting presentations given by leading scientists in the field. From the many abstracts that were submitted, the Scientific Committee selected several for an oral presentation. The remaining abstracts were presented as posters during the poster session. The participants of the symposium ranked the posters—resulting in three winners, each of whom were awarded an ESLHO poster prize.

Publications

In 2024, we published six publications on our collaborative work in peer-reviewed journals—all open access.

Update to existing EuroFlow educational book

We updated our EuroFlow educational book ‘EuroFlow-based flow cytometric diagnostic screening and classification of primary immunodeficiencies.;

The update has added a clearer focus on age-related reference databases for absolute counts of more than 70 lymphoid subsets in blood presented in updated tables.

To aid in the early diagnosis and classification of primary immunodeficiencies (PID), we’ve included figures with percentile bars of the most important lymphocyte subsets.

The publication part of the book is complemented with a EuroFlow manuscript on in-depth blood immune profiling of Good syndrome patients.

New EuroFlow educational book

We also composed a new EuroFlow educational book entitled ‘EuroFlow-based Flow Cytometric Diagnosis and Classification of Acute Leukemias and Mature B- and T-cell Malignancies.’

This offers an in-depth explanation of EuroFlow’s innovative approach to diagnosing and classifying hematological malignancies.

It presents years of research and publications and provides detailed insights into:

  • Acute leukemias, including specific subsets and database usage
  • Mature B-cell malignancies, featuring expert-independent classification and plasma cell detection

For mature T-cell malignancies, it describes a novel clonality testing strategy based on TRBC1 expression.

Share